
|Articles|November 27, 2007
NIH to meet over use of hydroxyurea for sickle cell disease
NIH to meet over use of hydroxyurea for sickle cell disease
Advertisement
How effective is the use of hydroxyurea to treat sickle cell anemia? The National Institutes of Health will be holding a consensus conference to address this issue. Sickle cell disease is an inherited blood disorder that affects up to 75,000 people in the United States, many of whom are from sub-Saharan Africa and other areas. The
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
5







































